Regresión de metástasis óseas en cáncer de próstata metastásico resistente a castración

R. Cortez-Betancourt , M. Pelayo-Nieto , E. Linden-Castro , I.A. Ramírez-Galindo , E.D. Rubio-Arellano , R.C. Rodríguez-Alvarado , A. González-Serrano , J.G. Sierra-Sosa , D. Espinosa-Perezgrovas , J.A. Morales-Covarrubias
{"title":"Regresión de metástasis óseas en cáncer de próstata metastásico resistente a castración","authors":"R. Cortez-Betancourt ,&nbsp;M. Pelayo-Nieto ,&nbsp;E. Linden-Castro ,&nbsp;I.A. Ramírez-Galindo ,&nbsp;E.D. Rubio-Arellano ,&nbsp;R.C. Rodríguez-Alvarado ,&nbsp;A. González-Serrano ,&nbsp;J.G. Sierra-Sosa ,&nbsp;D. Espinosa-Perezgrovas ,&nbsp;J.A. Morales-Covarrubias","doi":"10.1016/j.uromx.2015.12.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>There have been significant modifications in metastatic castration-resistant prostate cancer management in the last decade, with great changes in the treatment paradigm, even though the disease will ultimately continue to progress despite the currently available treatments.</p></div><div><h3>Case report</h3><p>A 72-year-old man diagnosed with castration-resistant prostate cancer underwent a bone scintigram that identified metastatic bone lesions. He was treated with abiraterone, with clinical and biochemical response. Follow-up revealed regression of bone metastasis documented in the bone scintigram.</p></div><div><h3>Conclusions</h3><p>This clinical case shows the particularity of apparent bone lesion regression in the context of metastatic castration-resistant prostate cancer after treatment with abiraterone acetate that also showed sustained clinical and biochemical response.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.12.002","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de urologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2007408515001639","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

There have been significant modifications in metastatic castration-resistant prostate cancer management in the last decade, with great changes in the treatment paradigm, even though the disease will ultimately continue to progress despite the currently available treatments.

Case report

A 72-year-old man diagnosed with castration-resistant prostate cancer underwent a bone scintigram that identified metastatic bone lesions. He was treated with abiraterone, with clinical and biochemical response. Follow-up revealed regression of bone metastasis documented in the bone scintigram.

Conclusions

This clinical case shows the particularity of apparent bone lesion regression in the context of metastatic castration-resistant prostate cancer after treatment with abiraterone acetate that also showed sustained clinical and biochemical response.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
耐去势转移性前列腺癌的骨转移消退
在过去十年中,转移性去势抵抗性前列腺癌的治疗发生了重大变化,治疗模式发生了巨大变化,尽管目前可用的治疗方法最终仍将继续发展。病例报告:一名72岁的男性被诊断患有去势抵抗性前列腺癌,接受了骨显像检查,确定了转移性骨病变。患者给予阿比特龙治疗,临床及生化反应良好。随访显示骨闪烁图显示骨转移灶消退。结论本病例显示了转移性去势抵抗性前列腺癌患者经醋酸阿比特龙治疗后骨损伤明显消退的特殊性,且临床和生化反应均持续。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Revista mexicana de urologia
Revista mexicana de urologia Medicine-Urology
CiteScore
0.20
自引率
0.00%
发文量
49
期刊介绍: Revista Mexicana de Urología (RMU) [Mexican Journal of Urology] (ISSN: 0185-4542 / ISSN electronic: 2007-4085) is bimonthly publication that disseminates research by academicians and professionals of the international medical community interested in urological subjects, in the format of original articles, clinical cases, review articles brief communications and letters to the editor. Owing to its nature, it is publication with international scope that disseminates contributions in Spanish and English that are rigorously reviewed by peers under the double blind modality. Neither journalistic documents nor those that lack rigorous medical or scientific support are suitable for publication.
期刊最新文献
Fe de errores de «Resultados obtenidos con nefrolitotomía percutánea y su correlación con las escalas de Guy y S.T.O.N.E. en un hospital de la Ciudad de México» [Rev Mex Urol. 2016;76:331] Blindness due to a systemic fungal infection in a patient with a ureteral catheter Permixon® en el tratamiento de los síntomas del tracto urinario inferior por hiperplasia benigna de próstata: Nuevas aportaciones Resultados de la nefrectomía laparoscópica en pacientes obesos y no obesos Alfa-1 bloqueantes y resultados urodinámicos en varones con síntomas del tracto urinario inferior relacionados con obstrucción benigna de próstata: ¿fin de la controversia?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1